ABBV vs PFE — AbbVie Inc. vs Pfizer Inc. Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
PFE is the better value pick
ABBV: $263.04 · Margin of Safety -29.8%|PFE: $27.35 · Margin of Safety -11.7%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
ABBVMetricPFE
$263.04Current Price$27.35
86.72Fair Value21.71
-67.0%Margin of Safety-20.6%
74.5P/E Ratio36.0
7.2P/S Ratio2.4
78.3P/B Ratio1.8
0.28Beta0.30
$464.8BMarket Cap$155.9B
0.03%Dividend Yield0.06%
9.8%Profit Margin6.8%
40.0%Operating Margin27.9%
—ROE5.0%
$61.2BRevenue$62.6B
16.2Forward P/E9.4
0.0Debt / Equity74.3
$278.61Analyst Target$28.88
financialProfile
AbbVie Inc.
Current Price$263.04
Fair Value$86.72
Margin of Safety-67.0%
P/E Ratio74.5
P/S Ratio7.2
P/B Ratio-78.3
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.2
Debt / Equity—
Analyst Target$278.61
Market Cap$464.8B
financialProfile
Pfizer Inc.
Current Price$27.35
Fair Value$21.71
Margin of Safety-20.6%
P/E Ratio36.0
P/S Ratio2.4
P/B Ratio1.8
Beta0.3
Dividend Yield0.06%
Profit Margin6.8%
Operating Margin27.9%
ROE5.0%
Revenue$62.6B
Forward P/E9.4
Debt / Equity74.3
Analyst Target$28.88
Market Cap$155.9B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
PFE offers better risk-adjusted value
Based on margin of safety (PFE wins) and beta safety (ABBV wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.